Drug Information

Drug General Information
Drug ID
D02XYA
Former ID
DNCL002769
Drug Name
Astuprotimut-R
Indication Adjuvant non-small-cell lung carcinoma; Melanoma [ICD9: 162, 172; ICD10:C33, C34, C43] Phase 3 [522494]
Company
GlaxoSmithKline
Target and Pathway
Target(s) Melanoma-associated antigen 3 Target Info Modulator [550432]
References
Ref 522494ClinicalTrials.gov (NCT00796445) A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor. U.S. National Institutes of Health.
Ref 550432National Cancer Institute Drug Dictionary (drug id 600553).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.